SERUM LPAI LIPOPROTEIN PARTICLES IN DIABETIC-PATIENTS WITH AND WITHOUT RENAL LESIONS OF DIFFERENT GRADES

被引:0
|
作者
PEYNET, J
GUILLAUSSEAU, PJ
LEGRAND, A
ALTMAN, JJ
FLOURIE, F
CHANSON, P
POUPON, J
NGUYEN, M
WARNET, A
LUBETZKI, J
ROUSSELET, F
机构
[1] HOP LARIBOISIERE,SERV MED B,F-75010 PARIS,FRANCE
[2] AURA,F-75013 PARIS,FRANCE
来源
DIABETES & METABOLISM | 1993年 / 19卷 / 04期
关键词
TYPE 1 DIABETES MELLITUS; TYPE 2 DIABETES MELLITUS; MICROALBUMINURIA; CHRONIC RENAL FAILURE; APOLIPOPROTEINS; PLASMA LIPIDS; LPAI LIPOPROTEIN PARTICLE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Among high density lipoprotein particles, LpAI particles which contain apolipoprotein Al alone, appear to be involved in cholesterol transport from peripheral tissues to the liver. The aim of this cross-sectional study was to examine serum LpAI particle concentrations in Type 1 and Type 2 diabetic patients with renal lesions of differing grades, in comparison with normal controls and with nondiabetic patients presenting with chronic renal failure. LpAI concentrations and LpAI-to-apo Al ratios were increased in Type 1 diabetic patients with normal albumin excretion. In Type 1 and in Type 2 diabetic patients with increased urinary albumin excretion, LpAI concentrations and LpAI-to-apo Al ratios were found to be not different from those of normal controls. In diabetic and in nondiabetic patients with chronic renal failure, LpAI concentrations were decreased. These abnormalities may contribute to the development of macrovascular complications.
引用
收藏
页码:355 / 360
页数:6
相关论文
共 50 条
  • [21] LIPOPROTEIN (A) AND VASCULAR-DISEASE IN DIABETIC-PATIENTS
    JAMES, RW
    BOEMI, M
    SIROLLA, C
    AMADIO, L
    FUMELLI, P
    POMETTA, D
    DIABETOLOGIA, 1995, 38 (06) : 711 - 714
  • [22] POLYENYLPHOSPHATIDYLCHOLINE IMPROVES THE LIPOPROTEIN PROFILE IN DIABETIC-PATIENTS
    KIRSTEN, R
    HEINTZ, B
    NELSON, K
    HESSE, K
    SCHNEIDER, E
    OREMEK, G
    NEMETH, N
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1994, 32 (02) : 53 - 56
  • [23] HYPERLIPOPROTEINEMIA IN DIABETIC-PATIENTS WITH AND WITHOUT ATHEROSCLEROSIS
    DELRIOVAZQUEZ, A
    VALORPEREA, R
    RICOLENZA, H
    ESPINOSPEREZ, D
    REVISTA CLINICA ESPANOLA, 1978, 148 (04): : 355 - 359
  • [24] ZINC AND COPPER IN THE SERUM OF DIABETIC-PATIENTS
    CAR, N
    CAR, A
    GRANIC, M
    SKRABALO, Z
    MOMCILOVIC, B
    BIOLOGICAL TRACE ELEMENT RESEARCH, 1992, 32 : 325 - 329
  • [25] SERUM LAMININ P1 CONCENTRATION IN DIABETIC-PATIENTS WITH AND WITHOUT MICROANGIOPATHIES
    KAWAZU, S
    TAKAHASHI, T
    WATANABE, T
    NEGISHI, K
    SUZUKI, M
    KATAYAMA, S
    ISHII, J
    DIABETOLOGIA, 1987, 30 (07) : A538 - A538
  • [26] SERUM CONCENTRATION OF LAMININ IN TYPE-I DIABETIC-PATIENTS WITH AND WITHOUT MICROANGIOPATHY
    HASSLACHER, C
    BROCKS, DG
    TRANSPLANTATION PROCEEDINGS, 1986, 18 (06) : 1534 - 1534
  • [27] EXAMINATION OF HBALC AND GLYCOSYLATED SERUM-ALBUMIN IN DIABETIC-PATIENTS WITH AND WITHOUT RETINOPATHY
    JERMENDY, G
    KAMMERER, L
    SZELENYI, J
    BROOSER, G
    POGATSA, G
    DIABETOLOGIA, 1981, 21 (03) : 287 - 287
  • [28] LEVELS OF GLYCOSAMINOGLYCANS IN SERUM OF DIABETIC-PATIENTS
    MALATHY, K
    KURUP, PA
    INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS, 1973, 10 (02): : 132 - 133
  • [29] SERUM GLYCATED LIPOPROTEINS IN TYPE-II DIABETIC-PATIENTS WITH AND WITHOUT COMPLICATIONS
    YEGIN, A
    OZBEN, T
    ANNALS OF CLINICAL BIOCHEMISTRY, 1995, 32 : 459 - 463
  • [30] SERUM PYRIDOXAL CONCENTRATIONS IN DIABETIC-PATIENTS
    DAVIS, RE
    MCCANN, VJ
    CALDER, JS
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1977, 7 (06): : 685 - 685